Lifescience-focussed BioVeda China Fund seeks $400m for fourth vehicle

Lifescience-focussed BioVeda China Fund seeks $400m for fourth vehicle

China-based investment firm with a focus on life sciences BioVeda China Fund (BVCF) is working on launching a $400 million fund, according to China Money Network quoting unnamed sources.

Having been founded in 2005, the private equity and venture capital firm had previously established three funds — one in 2006, the second in 2008 followed by another in 2014. Its third fund, BVCF III, hit its final close with $200 million from Adveg, Mayo Clinic Foundation, International Financial Corporation, Obviam, and Novartis.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter